Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on AnteoTech.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Neuroscientific announces breakthrough as Neuren gets ready for Phase 2 trial
News
ASX Small Cap Lunch Wrap: Back in green, but is it time to look away?
News
Top 10 at 10: These ASX stocks have come out swinging
News
Hot Money Monday: Resources rule the roost in January
Health & Biotech
This new AI Covid test could pump out a diagnosis quicker than a PCR
News
2020’s top 100 stocks have gained another 8pc this year on average; but two stocks rose 300pc+ again
Health & Biotech
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
News
Here are the top ASX large cap movers for Monday
Health & Biotech
ASX Health Stocks: AnteoTech initiates TGA submission, Zelira jumps 10pc after launching CBD-based acne gel
News
Closing Bell: ASX closes out choppy week, IPO rush continues, iron ore tanks
Health & Biotech
Chart of the Day: Could AnteoTech keep piling runs on the board?
News
ASX Small Cap Lunch Wrap: Who wasn’t invited to the party today?
Health & Biotech
ASX Health Stocks: Chimeric gets licence for CAR-T from U-Pen, Acrux gets nod from the FDA
Health & Biotech
ASX health stocks today: AdAlta (ASX:1AD) leads after successful Phase I study
Health & Biotech
Anteotech flags in-house scale up for its COVID-19 test kit, shares edge higher
News
Last Orders: Tech and energy stocks help the ASX closer higher
News